Click here to view program
Release Date: April 10, 2007
Expiration Date: April 10, 2008
Program Overview
This enduring activity is a group of lectures taken from the “8th Annual Perspectives in Lung Cancer” meeting in Seville, Spain on 2-3 March, 2007. Several thought leaders in the area of lung cancer therapy present a fascinating review of the development of multiple biologic agents for treatment of solid tumors. Clinical trial information relevant to lung cancer therapy is discussed and future directions are identified.
Target Audience
- Those interested in the development of targeted agents for use as monotherapy as well as in combination with chemotherapy in the therapy of solid tumors.
- Oncologists, radiation therapists, thoracic surgeons and other physicians in active clinical practice and/or research interested and/or involved in the management of patients with solid tumors, especially lung cancer.
Educational Objectives:
After successfully completing this program participants should be able to:
- Differentiate between different classes of targeted agents and summarize important clinical trial data relevant to the treatment of both non-small cell lung cancer and small cell lung cancer.
- Analyze the development of multiple biologic therapies and explain their properties in relation to treatment of solid tumors including non-small cell lung cancer.
- Discuss studies demonstrating the advantages of vaccine therapy in the management of solid tumors.
- Describe targeting pathways of newer biologic agents such as HDAC inhibitors, mTOR inhibitors, VEGFR inhibitors, and EGFR inhibitors and point out which cancers have demonstrated response to each class of agents.
- Distinguish which agents have shown synergistic activity with chemotherapy in the treatment of NSCLC and SCLC.
- Review documented toxicities of various targeted agents identified in early and later clinical trials in the therapy of lung cancer and other solid tumors.
Unapproved and Investigational Uses of Drugs and Devices
This webcast may contain information about experimental and other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) and/or other national regulatory agencies in the United States and other countries. Participants in the United States are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in this program before use. Participants from other countries should consult with their respective regulatory authorities.
The opinions expressed in this webcast are the opinions of the authors and do not necessarily reflect the opinions of Imedex®, Inc. or the meeting supporters.
Program Organizer
Imedex®, Inc.
4325 Alexander Drive
Alpharetta, GA 30022
Fax: +1(770) 751 7334
Imedex®, Inc. is an independent provider of Continuing Medical Education. Imedex®, Inc. has no proprietary or financial interest in medical or healthcare products over which the FDA has regulatory authority.
©2007 Imedex®, Inc. All rights reserved. Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
Click here to view program
Systems Requirements
- Windows 98/NT/2000/XP/Vista or Mac OS 9/X
- Internet Browser (Microsoft Internet Explorer 5.5 or later, Firefox, Netscape, Safari, etc.)
- Adobe Flash player 8 - Click here to download
- High-speed Internet connection
- Monitor settings: High color at 800 x 600 pixels
- Sound card and speakers
- Evaluation forms require Adobe Acrobat Reader
- Click here to download
|
